Healthcare Innovation: Advancing Treatments for Diabetes and Kidney Disease | Bayer
What healthcare innovations are on the horizon? This video explores how scientific advancements are leading to new answers for conditions like type 2 diabetes and kidney disease. Type 2 diabetes can lead to serious complications including kidney disease, affecting millions of patients worldwide. Bayer Pharmaceuticals is working at the forefront of scientific discovery to develop new treatments and therapies that address these interconnected conditions. Discover what's in Bayer's pipeline and how we're hoping scientific advancements will lead to breakthrough treatments for patients who need new options.
Suggested videos
Translating Discovery to Practice: Lessons from Developing Therapies for Diabetic Kidney Disease
NUGoKidney · 48:05
Every Moment Matters | Bayer 04 Leverkusen x Bayer Prostate Cancer Awareness
Bayer Global · 0:32
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
The Texas Heart Institute · 34:04
Bayer CEO Bill Anderson shares Q3 2026 Results | 90 Days in 90 Seconds
Bayer Global · 1:43
Innovations in the Diagnosis and Treatment of Chronic Kidney Disease
UCSF Department of Medicine · 56:30
The Start of A New World Order
David Bayer · 31:53
Advancing Research and Health for All: NIDDK Supports Research Across America
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 5:06
First-Quarter 2026 Financial Results in 90 Seconds with Bayer CEO Bill Anderson | Bayer
Bayer Global · 1:51
Artificial pancreas for diabetes treatment tops Cleveland Clinic's 2018 top 10 medical innovations
News 5 Cleveland · 2:11
Bayer | Who We Are
Bayer Global · 6:13
Living Well with Kidney Disease: Mind, Body, and Nutrition (N. Bates)
American Association of Kidney Patients · 40:56
Dr. Bijoy Sagar on Leading Bayer’s Global AI-First Transformation in Pharma & Agriculture
CAIO AI Leadership Podcast · 1:09:46